Recommendations on occupational radiation protection in interventional cardiology

 

The evolution in experience of the operators together with the continuous improvement of devices have allowed new procedures that we did not perform a few years ago and that we never imagined possible, not even for the most enthusiastic of interventional cardiologists.

Not a huge intellectual effort is required to say that the future will continue inexorably in the same direction. The same is happening in other specialties besides cardiology where surgery is being performed on increasingly complex cases.

However, it is logical that the progresses of science are not all positive news. More complex procedures take longer and automatically have higher radiation doses not only for the patient but also for medical and non-medical operators in the room.

In this sense, we believe it’s beneficial to highlight our concern about this issue in a multi-disciplinary framework group dedicated to radiation protection in interventional cardiology within the International Atomic Energy Agency (IAEA) based in Vienna, Austria. Writing about “Recommendations on occupational radiation protection in interventional cardiology”, it was decided to focus in the first instance on professional care and leave care of the patient until later.

We tried to write a practical approach where operators and ward staff can identify the most useful radiation protection measures and hope that their knowledge will influence an adequate prevention of stochastic as well as deterministic effects in the future. It gave us real satisfaction when a prestigious magazine, “Catheterization and Cardiovascular Interventions”, accepted our work for publication and, as such, we want to share this with all SOLACI partners.

Dr. Ariel Durán, FACC
SOLACI Radiation Safety Committee


Ariel Durán

More articles by this author

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...

EuroPCR 2026 | TAVI and Coronary Artery Disease: FFR-Guided PCI Showed Better Outcomes Than an Angiography-Guided Strategy

In patients undergoing TAVI, the concomitant presence of coronary artery disease continues to generate debate: whether coronary lesions should be treated before, during, or...

EuroPCR 2026 | Evolocumab Reduces Cardiovascular Events in Patients With Prior PCI Without Previous Myocardial Infarction: VESALIUS-CV Results

This presentation, delivered by Dr. Brian A. Bergmark and colleagues at EuroPCR 2026, detailed the results of the VESALIUS-CV trial, focusing specifically on the...

EuroPCR 2026 | Is It Safe to Stop Aspirin After One Month in MI Patients Undergoing PCI? TARGET-FIRST Analysis

This is a summary of the post-hoc analysis of the TARGET-FIRST study, presented by Dr. Giuseppe Tarantini at EuroPCR 2026, evaluating early aspirin discontinuation...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

Is left atrial appendage closure safe in patients with reduced ejection fraction?

Patients with heart failure with reduced ejection fraction (HFrEF) were excluded from the major randomized trials evaluating percutaneous left atrial appendage closure (LAAC), and...

Left Atrial Appendage Closure in Spain: Sustained Growth and Favorable Real-World Outcomes

Oral anticoagulation remains the standard treatment for stroke prevention in patients with atrial fibrillation. However, many patients have a high bleeding risk or contraindications...

HERA-TAVI: Intra-Annular vs Supra-Annular Valves in TAVI

The HERA-TAVI study is an international multicenter registry that compared the clinical and hemodynamic outcomes of contemporary self-expanding transcatheter heart valves with intra-annular (IA)...